“The urgency to treat optimally and to target: Avoiding long-term complications in type 2 diabetes with a focus on GLP-1 receptor agonists” (2023) Canadian Primary Care Today, 1(S07), pp. 2–6. doi:10.58931/cpct.2023.1S0717.